ArticleTherapeutic advances in medical oncology2025
A prospective observational study of inflammatory mediators in cerebrospinal fluid after intraoperative radiotherapy of brain tumors.
Article in Therapeutic advances in medical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malignant brain tumors, including gliomas and brain metastases, present therapeutic challenges due to their aggressive nature and high recurrence rates. Intraoperative radiotherapy (IORT) is a promising novel therapeutic approach that delivers immediate irradiation to the resection cavity. This may trigger a local and systemic immune response. However, the immunological effects of IORT remain poorly understood. Objectives: To investigate the immunomodulatory effects of IORT by analyzing perioperative profiles of inflammatory mediators (IMs) in patients undergoing surgical resection of malignant brain tumors. Design: A prospective observational cohort study comparing IM responses in patients undergoing brain tumor resection with and without IORT. Methods: In total, 44 patients undergoing surgical resection of brain tumors were included, with 20 receiving IORT and 24 serving as controls without IORT. In both groups, cerebrospinal fluid/wound fluid samples were collected from the resection cavity at several predefined intraoperative and postoperative time points. A multiplex proteomic assay was used to measure 19 IM involved in inflammation and immune activation. Results: IORT significantly increased the levels of seven IM (interleukin (IL)-1β, IL-6, IL-8, IP-10, MCP-1, MIP-1β, and VEGF) within the IORT group compared to baseline levels. When comparing to the non-IORT group, the increase in IL-1β was significantly greater for patients with metastases, while IL-10 also showed a trend toward significance. Conclusion: IORT induces distinct changes in levels of IM, which may contribute to improved tumor control. These findings provide novel insights into the immunomodulatory effects of IORT and may have implications for optimizing multimodal treatment strategies for malignant brain tumors. As an exploratory study with a limited sample size, the findings should be interpreted as hypothesis-generating.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.